{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T11:20:27Z","timestamp":1787656827991,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-02939-z","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:36:09Z","timestamp":1787654169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pembrolizumab in people with HIV-associated progressive multifocal leukoencephalopathy: a retrospective case series"],"prefix":"10.1007","author":[{"given":"Leyli","family":"Ghaeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Drauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"1","key":"2939_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awac237","volume":"146","author":"M Joly","year":"2023","unstructured":"Joly M, Conte C, Cazanave C, Le Moing V, Tattevin P, Delobel P, et al. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain. 2023;146(1):349\u201358.","journal-title":"Brain"},{"issue":"9","key":"2939_CR2","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1007\/s40121-025-01199-y","volume":"14","author":"M Elbaz","year":"2025","unstructured":"Elbaz M, Yahav D, Mina Y, Atamna A. JC polyomavirus infection: a narrative review. Infect Dis Ther. 2025;14(9):2007\u201328.","journal-title":"Infect Dis Ther"},{"issue":"16","key":"2939_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1212\/WNL.0000000000207622","volume":"101","author":"F Schweitzer","year":"2023","unstructured":"Schweitzer F, Laurent S, Cortese I, Fink GR, Silling S, Skripuletz T, et al. Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy. Neurology. 2023;101(16):700\u201313.","journal-title":"Neurology"},{"issue":"6","key":"2939_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11904-022-00626-w","volume":"19","author":"S Corey","year":"2022","unstructured":"Corey S, Smith BR, Cortese ICM. Promise and challenges of checkpoint inhibitor therapy for progressive multifocal leukoencephalopathy in HIV. Curr HIV AIDS Rep. 2022;19(6):580\u201391.","journal-title":"Curr HIV AIDS Rep"},{"issue":"7077","key":"2939_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077):682\u20137.","journal-title":"Nature"},{"issue":"12","key":"2939_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1\u201311.","journal-title":"Exp Mol Med"},{"issue":"17","key":"2939_CR7","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","volume":"380","author":"I Cortese","year":"2019","unstructured":"Cortese I, Muranski P, Enose-Akahata Y, Ha SK, Smith B, Monaco M, et al. Pembrolizumab treatment for progressive multifocal leukoencephalopathy. N Engl J Med. 2019;380(17):1597\u2013605.","journal-title":"N Engl J Med"},{"issue":"2","key":"2939_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13365-025-01243-0","volume":"31","author":"M Chiuchiarelli","year":"2025","unstructured":"Chiuchiarelli M, Micheli G, Segala FV, Giuliano G, Del Giacomo P, Dusina A, et al. Prolonged survival in HIV-associated progressive multifocal leukoencephalopathy treated with pembrolizumab: a case series on treatment and long-term follow-up. J Neurovirol. 2025;31(2):109\u201315.","journal-title":"J Neurovirol"},{"issue":"6","key":"2939_CR9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s13365-023-01180-w","volume":"29","author":"S Fan","year":"2023","unstructured":"Fan S, Liu M, Bai L, Chen S, Hou B, Lin N, et al. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China. J Neurovirol. 2023;29(6):692\u20138.","journal-title":"J Neurovirol"},{"key":"2939_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421993684","volume":"14","author":"N M\u00f6hn","year":"2021","unstructured":"M\u00f6hn N, Wattjes MP, Adams O, Nay S, Tkachenko D, Salge F, et al. PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy. Ther Adv Neurol Disord. 2021;14:1756286421993684.","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"2939_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/ana.26512","volume":"93","author":"X Boumaza","year":"2023","unstructured":"Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, et al. Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors. Ann Neurol. 2023;93(2):257\u201370.","journal-title":"Ann Neurol"},{"issue":"3","key":"2939_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamaneurol.2025.5318","volume":"83","author":"N M\u00f6hn","year":"2026","unstructured":"M\u00f6hn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, et al. Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy. JAMA Neurol. 2026;83(3):280\u20139.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2939_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17(1):37\u201351.","journal-title":"Nat Rev Neurol"},{"issue":"15","key":"2939_CR14","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology. 2013;80(15):1430\u20138.","journal-title":"Neurology"},{"issue":"5","key":"2939_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/ene.12963","volume":"23","author":"S Sainz-de-la-Maza","year":"2016","unstructured":"Sainz-de-la-Maza S, Casado JL, P\u00e9rez-El\u00edas MJ, Moreno A, Quereda C, Moreno S, et al. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy. Eur J Neurol. 2016;23(5):919\u201325.","journal-title":"Eur J Neurol"},{"issue":"11","key":"2939_CR16","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp.2009.179002","volume":"81","author":"MA Lima","year":"2010","unstructured":"Lima MA, Bernal-Cano F, Clifford DB, Gandhi RT, Koralnik IJ. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010;81(11):1288\u201391.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2939_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020967","volume":"6","author":"J Gasnault","year":"2011","unstructured":"Gasnault J, Costagliola D, Hendel-Chavez H, Dulioust A, Pakianather S, Mazet AA, et al. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS ONE. 2011;6(6):e20967.","journal-title":"PLoS ONE"},{"key":"2939_CR18","unstructured":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. National Institutes of Health, HIV Medicine Association, and Infectious Diseases Society of America. 2026. Progressive Multifocal Leukoencephalopathy\/JC Virus Infection. Available at: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/progressive."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02939-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:36:10Z","timestamp":1787654170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02939-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":18,"alternative-id":["2939"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02939-z","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the Berlin Medical Association (Berliner \u00c4rztekammer Eth-SB-26-018).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}